Breaking News
Get 40% Off 0
👀 Reveal Warren Buffett's stock picks that are beating the S&P 500 by +174.3% Get 40% Off

Midday movers: Pfizer, Ulta Beauty, UiPath and more

Published Dec 01, 2023 13:06 Updated Dec 01, 2023 17:12
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
© Reuters
 
DELL
+1.55%
Add to/Remove from a Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
DIS
+0.68%
Add to/Remove from a Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
MRVL
+6.10%
Add to/Remove from a Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
PFE
-1.81%
Add to/Remove from a Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
CRM
+3.00%
Add to/Remove from a Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
TSLA
-0.08%
Add to/Remove from a Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
(Updated - December 1, 2023 12:06 PM EST)

Investing.com -- Main U.S. indexes climbed following a speech from Fed Chair Jerome Powell. Powell said the Fed needs to move carefully on interest rates with risks more balanced, striking a slightly dovish tone.

Here are some of the biggest U.S. stock movers today:

Walt Disney (NYSE:DIS) stock erased a pre-open gain and declined 0.6%. The entertainment giant announced plans to reinstate its dividend with a 30-cent per share payout for the second half of its fiscal year, signaling a recovery phase after the pandemic-induced hiatus.

Tesla (NASDAQ:TSLA) stock fell 1% after the electric-vehicle maker started deliveries of its Cybertruck electric pickup on Thursday, with a starting price of $60,990, above its original forecast.

Alibaba (NYSE:BABA) ADRs fell 2% after Morgan Stanley (NYSE:MS) downgraded the e-commerce giant to ‘equal weight’ from ‘overweight’, citing slower turnaround in customer management revenue.

Pfizer (NYSE:PFE) stock fell 4% after the drugs giant scrapped its plan to advance a twice-daily version of its oral weight-loss drug into late-stage studies.

Fisker (NYSE:FSR) stock rose 11% after the electric-vehicle maker said it will scale down production this month, and produce fewer cars this year than its previous guidance, to prioritize cash for working capital needs.

Marvell (NASDAQ:MRVL) stock fell 4.8% after the chipmaker's fourth-quarter revenue forecast fell short of expectations, while also reporting declining third-quarter revenue.

Ulta Beauty (NASDAQ:ULTA) stock soared 12% after the cosmetics retailer raised the lower end of its annual net sales forecast and named Paula Oyibo its new chief financial officer.

UiPath (NYSE:PATH) stock jumped 26% after the automation software firm beat third-quarter revenue estimates, amid strength in the licenses and subscription-services businesses.

Salesforce (NYSE:CRM) stock climbed 3.4%, adding to yesterday’s gain after reporting better than expected earnings and raising guidance.

Dell Technologies (NYSE:DELL) stock declined 5% after it reported disappointing results for the third quarter. EPS topped consensus but a revenue shortfall spooked investors.


Additional reporting by Louis Juricic
Midday movers: Pfizer, Ulta Beauty, UiPath and more
 

Related Articles

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email